Future Publishing Solutions (FPS), organizers of Africa’s largest 100% dedicated pharmaceutical event, SAPHEX, are pleased to welcome another influential company as a silver sponsor for the show.
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world.
Gilead’s portfolio of products includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.
The company was founded in 1987 in Foster City, California. Since then, it has grown to become one of the world’s largest biopharmaceutical companies, with 8,000 employees across six continents and revenue for 2016 totalling over USD$30 billion.
Future Publishing Solutions CEO, Scott Colman, praised Gilead’s position as a silver sponsor, and highlighted the growing number of companies who are signing up to SAPHEX as exhibitors and sponsors.
“Gilead Sciences’ participation as a silver sponsor exemplifies that global pharmaceutical companies are viewing Saphex as a legitimate platform, to form business partnerships and connections in Africa.
“SAPHEX is proving to be an attractive prospect for companies at all stages of the pharmaceutical supply chain who are looking to conduct business in the African pharmaceutical industry.”